CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

HFSA's 2026 Annual Scientific Meeting to Feature Late-Breaking Trials That Could Reshape Heart Failure Treatment

ConferenceNeutral
AI Analysis

Summary

HFSA announced its 2026 Annual Scientific Meeting scheduled for October 9-12, 2026 in Phoenix, Arizona, which will feature late-breaking clinical research data on heart failure treatments including pharmacotherapy, imaging, diagnostics, and device therapy for cardiomyopathy.

Importance:3/10
Sentiment:
0.00
heart_failurelate_breaking_trialspharmacotherapyimagingdiagnosticsdevice_therapycardiomyopathyconference
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on September 18, 2026 1:17 PM

Read Original